AVIATOR 4247040WRecalls & reported problems
Cordis US Corp. · AVIATOR PLUS .014 7.0X40 142CM · Class 2
- Adverse event reports
- 1
- Deaths reported
- 0
- Injuries reported
- 0
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 20705032005965), received between May 1, 2020 and May 1, 2020 — classified as 1 malfunction.
The most frequently reported specific device problem is “Detachment of Device or Device Component” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. How this data works · Data updated Oct 13, 2026.
Most reported problems
Device problems
- Detachment of Device or Device Component1
- Difficult to Remove1
Patient problems
- No Consequences Or Impact To Patient1
Recent adverse event reports
The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.
MalfunctionMay 1, 2020Difficult to Remove; Detachment of Device or Device Component; Difficult to Remove; Detachment of Device or Device Component
DURING USE OF .014 7.0X40 142CM AVIATOR PLUS BALLOON CATHETER (BC) WAS DEFLATED AND ATTEMPTED TO BE REMOVED FROM THE SHEATH HOWEVER, IT COULD NOT BE REMOVED FROM THE SHEATH AND THE SHAFT GOT SEPARATED. THE PROCEDURE WAS COMPLETED BECAUSE THERE WAS NO PROBLEM. THERE WAS NO REPORTED PATIENT INJURY. THIS WAS VASCULAR ACCESS INTERVENTION THERAPY (VAIVT) CASE. THE LESION WAS THE STENOSIS JUST ABOVE THE ANASTOMOSIS. ARTERIAL APPROACHED WAS MADE. THE SEPARATION OCCURRED AT THE OUTLET OF THE SHEATH, AND THE REST WAS INSIDE THE SHEATH AND COULD BE REMOVED. THE SHEATH WAS REINSERTED, AND FINAL IMAGING WAS PERFORMED TO CHECK FOR ANY RESIDUE. DURING THE PRODUCT EVALUATION, THE BALLOON WAS OBSERVED SEPARATED NEAR THE PROXIMAL SEAL AREA OF THE BALLOON.
Patient problems: No Consequences Or Impact To Patient
MAUDE report 10017580 ↗
Other Catheter, angioplasty, peripheral, transluminal devices
- Coyote™ ES H74939135152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal879 reports
- Coyote™ ES H74939135204010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal585 reports
- Coyote™ ES H74939135202010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal437 reports
- Coyote™ ES H74939135304010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal384 reports
- Coyote™ ES H74939135404010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal293 reports
- Coyote™ ES H74939134152010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal279 reports
- Coyote™ H74939185202210Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal200 reports
- Coyote™ ES H74939135254010Boston Scientific Corporation · Catheter, angioplasty, peripheral, transluminal127 reports
Sources: FDA GUDID, MAUDE and Medical Device Recalls via openFDA. openFDA data is not validated for clinical or regulatory use.